BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21344537)

  • 1. Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas.
    Chien HT; Liao CT; Huang SF; Chen IH; Liu TY; Jou YS; Wang HM; Hsieh LL
    Genes Chromosomes Cancer; 2011 May; 50(5):358-69. PubMed ID: 21344537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma.
    Kakimoto Y; Yamamoto N; Shibahara T
    Oncol Rep; 2008 Nov; 20(5):1195-200. PubMed ID: 18949421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma.
    Kayahara H; Yamagata H; Tanioka H; Miki T; Hamakawa H
    J Hum Genet; 2001; 46(6):335-41. PubMed ID: 11393537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent microsatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas.
    Lin SC; Chang MF; Chung MY; Chang CS; Kao SY; Liu CJ; Chang KW
    J Oral Pathol Med; 2005 Apr; 34(4):209-13. PubMed ID: 15752255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of single nucleotide polymorphism arrays to identify a novel region of loss on chromosome 6q in squamous cell carcinomas of the oral cavity.
    Tong BC; Dhir K; Ha PK; Westra WH; Alter BP; Sidransky D; Koch WM; Califano JA
    Head Neck; 2004 Apr; 26(4):345-52. PubMed ID: 15054738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent allelic loss of 21q11.1 approximately q21.1 region in advanced stage oral squamous cell carcinoma.
    Chen L; Wong MP; Cheung LK; Samaranayake LP; Baum L; Samman N
    Cancer Genet Cytogenet; 2005 May; 159(1):37-43. PubMed ID: 15860355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of 3p26.3 is an independent prognostic factor in patients with oral squamous cell carcinoma.
    Uchida K; Oga A; Nakao M; Mano T; Mihara M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
    Oncol Rep; 2011 Aug; 26(2):463-9. PubMed ID: 21617881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous oral carcinomas: independent or common clonal origin?
    Scholes AG; Woolgar JA; Boyle MA; Brown JS; Vaughan ED; Hart CA; Jones AS; Field JK
    Cancer Res; 1998 May; 58(9):2003-6. PubMed ID: 9581845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma.
    Wang X; Fan M; Chen X; Wang S; Alsharif MJ; Wang L; Liu L; Deng H
    Oral Oncol; 2006 Aug; 42(7):740-4. PubMed ID: 16455286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Jan; 35(1):1-9. PubMed ID: 18095987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma.
    Weber F; Xu Y; Zhang L; Patocs A; Shen L; Platzer P; Eng C
    JAMA; 2007 Jan; 297(2):187-95. PubMed ID: 17213402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aberration on chromosome 10 in human oral squamous cell carcinoma.
    Yamashita Y; Miyakawa A; Mochida Y; Aisaki K; Yama M; Shiiba M; Watanabe T; Yokoe H; Uzawa K; Imai Y; Tanzawa H
    Int J Oncol; 2002 Mar; 20(3):595-8. PubMed ID: 11836574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
    Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
    Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity of D9S162: molecular predictor for treatment response in oral carcinoma.
    Murali A; Sailasree R; Sebastian P; Rejnish Kumar R; Varghese BT; Kannan S
    Oral Oncol; 2011 Jul; 47(7):571-6. PubMed ID: 21592845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.